Abstract
The synthesis and structure – activity relationships (SAR) antitumor activities of monopyrazolic and bipyrazolic tripodal derivatives are reported here for the first time. The ten products were tested against three human cancer cell lines including breast (MDA-MB231), prostate (PC3) and colorectal (LoVo) cancers. In bipyrazolic series, most of them exhibited a moderate antitumor activity against three human cancer cell lines with an order of 5 > 7 > 8 in case of colorectal cancer and 5 > 7 ≉ 8 in case of breast and prostate cancers.
Keywords: Antitumor activity, Bipyrazoles, LoVo, MDA-MB231, PC3, Synthesis, Pyrazole derivatives, biologically active heterocyclic compounds, bipyrazole-3-carboxylates, Biological Assays, aniline ring, macrocyclic, MTT tests, DMSO, moiety, antitumor activity
Letters in Drug Design & Discovery
Title: One Pot Synthesis and In Vitro Antitumor Activity of some Bipyrazolic Tripodal Derivatives
Volume: 9 Issue: 3
Author(s): Smaail Radi, Yahya Toubi, Nihed Draoui, Olivier Feron and Olivier Riant
Affiliation:
Keywords: Antitumor activity, Bipyrazoles, LoVo, MDA-MB231, PC3, Synthesis, Pyrazole derivatives, biologically active heterocyclic compounds, bipyrazole-3-carboxylates, Biological Assays, aniline ring, macrocyclic, MTT tests, DMSO, moiety, antitumor activity
Abstract: The synthesis and structure – activity relationships (SAR) antitumor activities of monopyrazolic and bipyrazolic tripodal derivatives are reported here for the first time. The ten products were tested against three human cancer cell lines including breast (MDA-MB231), prostate (PC3) and colorectal (LoVo) cancers. In bipyrazolic series, most of them exhibited a moderate antitumor activity against three human cancer cell lines with an order of 5 > 7 > 8 in case of colorectal cancer and 5 > 7 ≉ 8 in case of breast and prostate cancers.
Export Options
About this article
Cite this article as:
Radi Smaail, Toubi Yahya, Draoui Nihed, Feron Olivier and Riant Olivier, One Pot Synthesis and In Vitro Antitumor Activity of some Bipyrazolic Tripodal Derivatives, Letters in Drug Design & Discovery 2012; 9 (3) . https://dx.doi.org/10.2174/157018012799129792
DOI https://dx.doi.org/10.2174/157018012799129792 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Progranulin Regulates Inflammation and Tumor
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry New Developments in Systemic Therapy for Hepatocellular Carcinoma
Current Cancer Therapy Reviews Correlation between Potassium Channel Expression and Sensitivity to Drug-induced Cell Death in Tumor Cell Lines
Current Pharmaceutical Design Pediatric Immune Dysfunction and Health Risks Following Early-Life Immune Insult
Current Pediatric Reviews IAPs as a Target for Anticancer Therapy
Current Cancer Drug Targets In Vitro and In Vivo Evaluation of Guar Gum-Based Matrix Tablets of Rofecoxib for Colonic Drug Delivery
Current Drug Delivery Reversing Breast Cancer Stem Cell into Breast Somatic Stem Cell
Current Pharmaceutical Biotechnology Bioinformatic Application in Proteomic Research on Biomarker Discovery and Drug Target Validation
Current Bioinformatics Cellular and Subcellular Imaging in Live Mice Using Fluorescent Proteins
Current Pharmaceutical Biotechnology Alternative Splice Variants of Survivin as Potential Targets in Cancer
Current Drug Discovery Technologies Modulation of Signaling Enhances the Efficacy of the Combination of Satraplatin and Erlotinib
Current Drug Targets Progesterone Receptor Agonists and Antagonists as Anticancer Agents
Mini-Reviews in Medicinal Chemistry The Power of Matrix Factorization: Methods for Deconvoluting Genetic Heterogeneous Data at Expression Level
Current Bioinformatics Quality Survival with Fertility after Gynaecological and other Cancers
Current Women`s Health Reviews The Smart Targeting of Nanoparticles
Current Pharmaceutical Design Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug Treatment
Current Medicinal Chemistry Novel Functionalization for Maximizing Cell Turnover from Microcarrier
Current Biotechnology Modulation of MMPs by Cell Surface Integrin Receptor α5β1
Anti-Cancer Agents in Medicinal Chemistry Abelson Tyrosine-Protein Kinase 1 as Principal Target for Drug Discovery Against Leukemias. Role of the Current Computer-Aided Drug Design Methodologies
Current Topics in Medicinal Chemistry Anticancer Potential of Aguerin B, a Sesquiterpene Lactone Isolated from <i>Centaurea behen</i> in Metastatic Breast Cancer Cells
Recent Patents on Anti-Cancer Drug Discovery